←Back to Expert Scholars
Translational Medicine / 转化医学Myeloid Reprogramming, Combination IO
Michael A. Curran
PhD
🏢MD Anderson Cancer Center🌐USA
Associate Professor of Immunology
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Michael Curran investigates myeloid-directed combination immunotherapies to overcome cold tumor microenvironments. His preclinical studies with CD40 agonists and checkpoint combinations have informed multiple clinical trials converting non-inflamed tumors. He directs the IO platform at MD Anderson ORBIT.
Share:
🧪Research Fields 研究领域
myeloid-targeted therapy
combination checkpoint
anti-CD40 preclinical
immunosuppressive microenvironment
cold tumor conversion
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Michael A. Curran 的研究动态
Follow Michael A. Curran's research updates
留下邮箱，当我们发布与 Michael A. Curran（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment